Belotecan Versus Topotecan for Recurrent Ovarian Cancer: A Randomized, Open-label, Parallel-group Phase IIb Trial

Clinical trial NCT01630018 · COMPLETED

Trial details

NCT number: NCT01630018
Sponsor: Chong Kun Dang Pharmaceutical
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Epithelial Ovarian Cancer

Start date: 2011-01-01
Primary completion: 2014-06-01
Enrollment: 141

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.